Brief: Spago Nanomedical Q2 Operating Loss Widens To SEK 4.5 Mln

Spago Nanomedical AB (publ)

22/08/2019 09:52

Aug 22 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.TE :
    * Q2 OPERATING LOSS SEK 4.5 MILLION VERSUS LOSS SEK 3.1
MILLION
    * Q2 NET SALES SEK 30,000 VERSUS SEK 0 YEAR AGO

Source text for Eikon:  ID:nNDL8hKFML 
Further company coverage:  SPAGO.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))